Literature DB >> 22351107

Pacemaker deactivation: withdrawal of support or active ending of life?

Thomas S Huddle1, F Amos Bailey.   

Abstract

In spite of ethical analyses assimilating the palliative deactivation of pacemakers to commonly accepted withdrawings of life-sustaining therapy, many clinicians remain ethically uncomfortable with pacemaker deactivation at the end of life. Various reasons have been posited for this discomfort. Some cardiologists have suggested that reluctance to deactivate pacemakers may stem from a sense that the pacemaker has become part of the patient's "self." The authors suggest that Daniel Sulmasy is correct to contend that any such identification of the pacemaker is misguided. The authors argue that clinicians uncomfortable with pacemaker deactivation are nevertheless correct to see it as incompatible with the traditional medical ethics of withdrawal of support. Traditional medical ethics is presently taken by many to sanction pacemaker deactivation when such deactivation honors the patient's right to refuse treatment. The authors suggest that the right to refuse treatment applies to treatments involving ongoing physician agency. This right cannot underwrite patient demands that physicians reverse the effects of treatments previously administered, in which ongoing physician agency is no longer implicated. The permanently indwelling pacemaker is best seen as such a treatment. As such, its deactivation in the pacemaker-dependent patient is best seen not as withdrawal of support but as active ending of life. That being the case, clinicians adhering to the usual ethical analysis of withdrawal of support are correct to be uncomfortable with pacemaker deactivation at the end of life.

Entities:  

Mesh:

Year:  2012        PMID: 22351107     DOI: 10.1007/s11017-012-9213-5

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN: 1386-7415


  19 in total

Review 1.  The rule of double effect: clearing up the double talk.

Authors:  D P Sulmasy; E D Pellegrino
Journal:  Arch Intern Med       Date:  1999-03-22

2.  Contemplating total artificial heart inactivation in cases of futility.

Authors:  Katrina A Bramstedt
Journal:  Death Stud       Date:  2003-05

3.  HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.

Authors:  Rachel Lampert; David L Hayes; George J Annas; Margaret A Farley; Nathan E Goldstein; Robert M Hamilton; G Neal Kay; Daniel B Kramer; Paul S Mueller; Luigi Padeletti; Leo Pozuelo; Mark H Schoenfeld; Panos E Vardas; Debra L Wiegand; Richard Zellner
Journal:  Heart Rhythm       Date:  2010-05-14       Impact factor: 6.343

4.  Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.

Authors:  G Neal Kay; Gregory T Bittner
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06

5.  Ontology or phenomenology? How the LVAD challenges the euthanasia debate.

Authors:  Felicitas Kraemer
Journal:  Bioethics       Date:  2011-07-29       Impact factor: 1.898

6.  Decisions near the end of life: professional views on life-sustaining treatments.

Authors:  M Z Solomon; L O'Donnell; B Jennings; V Guilfoy; S M Wolf; K Nolan; R Jackson; D Koch-Weser; S Donnelley
Journal:  Am J Public Health       Date:  1993-01       Impact factor: 9.308

7.  Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Authors:  Suraj Kapa; Paul S Mueller; David L Hayes; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

8.  Moral fictions and medical ethics.

Authors:  Franklin G Miller; Robert D Truog; Dan W Brock
Journal:  Bioethics       Date:  2010-11       Impact factor: 1.898

9.  Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.

Authors:  Paul S Mueller; C Christopher Hook; David L Hayes
Journal:  Mayo Clin Proc       Date:  2003-08       Impact factor: 7.616

10.  "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life.

Authors:  Nathan E Goldstein; Davendra Mehta; Ezra Teitelbaum; Elizabeth H Bradley; R Sean Morrison
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

View more
  6 in total

Review 1.  Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients.

Authors:  Mina M Benjamin; Christine A Sorkness
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  The prevalence and contents of advance directives in patients with pacemakers.

Authors:  Dario Pasalic; Tanya H Tajouri; Abigale L Ottenberg; Paul S Mueller
Journal:  Pacing Clin Electrophysiol       Date:  2013-11-11       Impact factor: 1.976

3.  An Ethical Analysis of Withdrawal of Therapy in Patients with Implantable Cardiac Electronic Devices: Application of a Novel Decision Algorithm.

Authors:  G Neal Kay; Frank Pelosi
Journal:  Linacre Q       Date:  2013-11-01

4.  Features and outcomes of patients who underwent cardiac device deactivation.

Authors:  Lillian C Buchhalter; Abigale L Ottenberg; Tracy L Webster; Keith M Swetz; David L Hayes; Paul S Mueller
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

Review 5.  Scarce-Resource Allocation and Patient Triage During the COVID-19 Pandemic: JACC Review Topic of the Week.

Authors:  James N Kirkpatrick; Sarah C Hull; Savitri Fedson; Brendan Mullen; Sarah J Goodlin
Journal:  J Am Coll Cardiol       Date:  2020-05-11       Impact factor: 24.094

6.  Characteristics of Clinicians Are Associated With Their Beliefs About ICD Deactivation: Insight From the DECIDE-HF Study.

Authors:  Florence Landry-Hould; Blandine Mondésert; Andrew G Day; Heather J Ross; Judith Brouillette; Brian Clarke; Shelley Zieroth; Mustafa Toma; Marie-Claude Parent; Robert A Fowler; John J You; Anique Ducharme
Journal:  CJC Open       Date:  2021-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.